Clinical Trials Browser

Interventional × Pruritus × Aprepitant × Clear all

NCT06931119 2025-04-17

Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients

Phase 1 Not yet recruiting

Pruritus

NCT02646020 2021-05-18

EGFR-TKIs

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Pruritus

NCT01625455 2017-05-10

Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome

Phase 4 Terminated

7 enrolled 7 charts

Pruritus, Sezary Syndrome